chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Balance disorder, Chest pain, Dizziness, Dyspnoea
Clinical narrative: This is a spontaneous report from a contactable physician. This physician reported for a 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via intramuscular route of administration on 26Mar2021 12:30 in Left arm as dose 2, single (at the age of 50 years) for covid-19 immunisation. Medical history included DM (Diabetes mellitus), HTN (Hypertension) (Newly diagnosed) and covid-19 and concomitant medication was not reported. The patient had no known past drug allergies. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via an unspecified route of administration on 23Feb2021 as dose1, single for covid-19 immunisation. The patient was diagnosed with COVID-19 prior to vaccination. It is unknown whether the patient was tested for COVID-19 post vaccination. On 26Mar2021 at 02:00 am the patient experienced developed dizziness, left arm pain, left chest pain and difficulty breathing as a treatment the patient took 3 Advils. These symptoms lasted for 1 day. On 13Apr2021 Dizziness recurred with Nausea/Vomiting, disequilibrium, feeling like walking sideway and about to fall. Headache and gurgling stomach. The AE resulted in physician office visit. The patient received Meclizine and Advil as a treatment drug for events. Outcome of events left arm pain and difficulty breathing resolved in 2021, for event dizziness it was Not recovered/not resolved and for rest of the events the Outcome was unknown.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Presyncope, Vomiting
Clinical narrative: This is a spontaneous report from a contactable physician. This physician reported for a 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via intramuscular route of administration on 26Mar2021 12:30 in Left arm as dose 2, single (at the age of 50 years) for covid-19 immunisation. Medical history included DM (Diabetes mellitus), HTN (Hypertension) (Newly diagnosed) and covid-19 and concomitant medication was not reported. The patient had no known past drug allergies. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via an unspecified route of administration on 23Feb2021 as dose1, single for covid-19 immunisation. The patient was diagnosed with COVID-19 prior to vaccination. It is unknown whether the patient was tested for COVID-19 post vaccination. On 26Mar2021 at 02:00 am the patient experienced developed dizziness, left arm pain, left chest pain and difficulty breathing as a treatment the patient took 3 Advils. These symptoms lasted for 1 day. On 13Apr2021 Dizziness recurred with Nausea/Vomiting, disequilibrium, feeling like walking sideway and about to fall. Headache and gurgling stomach. The AE resulted in physician office visit. The patient received Meclizine and Advil as a treatment drug for events. Outcome of events left arm pain and difficulty breathing resolved in 2021, for event dizziness it was Not recovered/not resolved and for rest of the events the Outcome was unknown.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report received from a contactable consumer or other non-health care professional. A patient of unspecified age and gender received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received vaccine Facility in Pharmacy or Drug Store. Reporter stated, on an unspecified patient got Shingles in the same arm as the vaccinee 9 days later. patient happen to know two other people who also got shingles after their vaccine. It could be a coincidence, but patient thought it was worth reporting for your tracking purposes. The outcome of the event was reported as unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021417121 same reporter/AE/drug, different patient
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: 10 days after the second shot I was in excruciating pain for 36 hours.; It was like I had shingles all over again without the rash.; This is a spontaneous report from a contactable consumer (patient). A 70-year-old patient of an unspecified gender received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: ER8737) via an unspecified route of administration in arm left on 01Apr2021 as dose 2, single (age at vaccination: 70 years) for COVID-19 immunisation. Medical history included shingles, post hermetic neuralgia, both from an unknown date and unknown if ongoing I have suffered from post hermetic neuralgia since having shingles in 2013. Concomitant medications were not reported. Historical vaccine includes bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number: EN6206) via an unspecified route of administration in arm left on 11Mar2021 12:00 AM as dose 1, single for COVID-19 immunisation. No other vaccine in four weeks, no known allergies. No COVID prior vaccination and did not tested COVID post vaccination. The episodes post hermetic neuralgia can be painful and erratic. I had gotten used to the pain. On 18Mar2021 12:15AM, after my first shot I noticed I was having more occurrences of problems with the PHN. On an unspecified date Apr2021, 10 days after the second shot I was in excruciating pain for 36 hours. It was like I had shingles all over again without the rash. The severe pain subsided within three days So I am just back to my normal PHN issues. The clinical outcome of the event 10 days after the second shot I was in excruciating pain for 36 hours was resolving and the event it was like I had shingles all over again without the rash was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles to right neck, ear, back of head on right side.; This is a spontaneous report from a contactable consumer. A 73-years-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 15Mar2021 14:00 PM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included diverticulosis, HTN, hypothyroidism, arthritis pain lower back from an unknown date and unknown if ongoing. Patient had allergy to adhesives tape. Concomitant medications included duloxetine (DULOXETINE), colecalciferol (VIT D3), cyanocobalamin (VIT B12), levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient previously took celebrex and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Apr2021 patient experienced shingles to right neck, ear, back of head on right side. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment with Valtrex. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch cannot be obtained. No further in-formation is expected.
Sex: M
Vaccine: COVID19
Symptoms: Seasonal allergy
Clinical narrative: seasonal allergy; This is a spontaneous report from a contactable consumer (patient) via -sponsored program Support. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: not reported) via an unspecified route of administration on 16Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced seasonal allergy on an unspecified date. He was wondering if he can take allergy medication in case his allergy triggers. The outcome of event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I came down with Shingles about 12Apr2021. I have no idea if this is a side effect of the vaccine, but felt I should report it because of seeing this on the news.; This is a spontaneous report received from a contactable consumer or other non hcp. A 77-years-old female patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EN6205),via an unspecified route of administration, administered in Arm Left on 09Mar2021 14:00,at the age of 77 years old, as Dose 2,single for covid-19 immunization.Medical history included atrial fibrillation from an unknown date and unknown if ongoing. Concomitant medications included rivaroxaban (XARELTO), metoprolol taken for an unspecified indication, start and stop date were not reported.The patient experienced she came down with shingles about 12apr2021,13:00. Patient had no idea if this is a side effect of the vaccine.Therapeutic measures were taken as a result of shingles.The outcome of the event was recovering.The patient was treated with Valacyclovir.The patient had not received any other vaccine within 4 weeks.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.The patient previously received her 1st dose of Pfizer covid vaccine on 18Feb2021 02:30 PM, lot number EM9810.The patient had no allergies.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Herpes zoster, Neck pain
Clinical narrative: Shingles - left arm palm and fingers; pain in left shoulder and neck; pain in left shoulder and neck; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN5318, Expiration date: not reported), via an unspecified route of administration in arm left on 02Feb2021 at 15:00 (at the age of 74-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was reported as unknown. The patient had any known allergies were reported as unknown. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL1283, Expiration date: not reported), via an unspecified route of administration in arm right on 12Jan2021 (at the age of 74-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. Covid prior vaccination and Covid tested post vaccination was reported as unknown. On 06Feb2021, the patient experienced pain in left shoulder and neck, then went to emergency room on 13Feb2021 and diagnosed with Shingles - left arm palm and fingers. The AE resulted in emergency room/department or urgent care. Treatment was received for the events and treatment medications included valtrex, prednisone, gabapentin. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Got shingles 2 weeks after covid vaccine; This is a spontaneous report from a contactable consumer (patient herself) via COVID-19 Adverse Event Self-Reporting Solution. A 46 years old non -pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: 6198) via an unspecified route, administered in Left Arm on 22Feb2021 at 14:15 (46-year-old at vaccination) as a Dose number unknown, Single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient medical history was not reported. No known allergies was reported. The patient's concomitant medication(s) included semaglutide (OZEMPIC), bupropion hydrochloride (WELLBUTRIN) within two weeks of vaccination. Vaccination Facility type was reported as Other. The patient was not diagnosed with Covid prior vaccination. The patient had not received any other vaccine in four weeks prior vaccination. On 03Mar2021 (2 weeks after covid vaccine), the patient had experienced shingles. These adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care visit. The patient received Lyrica, acyclovir as treatment medication for the event. The patient had not tested for Covid post vaccination. The outcome of the event shingles was recovering.  No follow-up attempts are required. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Alopecia areata, SARS-CoV-2 test
Clinical narrative: Alopecia areata; Sudden hair loss in patches on scalp and beard; This is a spontaneous report from a contactable consumer or other non hcp. A 26-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN6199) via an unspecified route of administration in Arm Left on 09Mar2021 (age at vaccination 26years old) as single dose for covid-19 immunisation. Medical history included testis cancer, drug hypersensitivity, all from an unknown date and unknown if on-going. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included famotidine (FAMOTIDINE); lysine (LYSINE); calcium carbonate (TUMS [CALCIUM CAR-BONATE]), all taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had been tested for COVID-19. On 12Mar2021 the patient experienced alopecia areata, sudden hair loss in patches on scalp and beard. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 20Apr2021. The patient received treatment with steroid cream for the adverse events. The clinical outcome of the event was not recovered. Therapeutic measures were taken as a result of alopecia areata, sudden hair loss in patches on scalp and beard.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles that started 3 days following the 1st vaccine administration.; This is a spontaneous report from a contactable consumer (Patient). A 52-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; lot number: ER8732), via an unspecified route of administration on 30Mar2021 at 14:30(at the age of 52-years-old) administered in Arm Left as a single dose for COVID-19 immunisation at hospital. Medical history included allergies: Sulfa from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took amoxicillin and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Apr2021 at 16:30, the patient experienced Shingles that started 3 days following the 1st vaccine administration. Therapeutic measures were taken as a result of shingles and treatment included 7-day course of Valtrex. The adverse event did result Doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes simplex, Herpes zoster
Clinical narrative: Experiencing herpes/shingles; Experiencing herpes/shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration on 05Jan2021 (Batch/Lot Number: EL0142) as dose 2, single for covid-19 immunization (at the age of 60-years-old). The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, as single dose for COVID-19 immunization. Facility type vaccine was reported as hospital. Patient had no covid prior vaccination. Patient was not tested for covid post vaccination. Patient had not received any other vaccine in four weeks. It was reported that since the second dose of the vaccine the patient experiencing herpes/shingles like reaction 07Apr2021. Ae resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events with antiviral medication. The outcome of the events was recovered on an unspecified date in 2021.   No follow-up attempts are required. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 50-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 05Apr2021 at 09:00 AM (Batch/Lot Number: EW0151) as dose 1, single for covid-19 immunization (at the age of 50-years-old). Medical history included hypertension from an unknown date and unknown if ongoing. The concomitant medications included unspecified medication (other medications uses in two weeks prior vaccination). The patient had no known allergies. Patient had no covid prior vaccination. The patient has not been tested for covid post vaccination. Patient had not received other vaccine in four weeks. It was reported that after receiving the dose of vaccine on the patient experienced shingles on 11Apr2021. Ae resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles with Valacyclovir. The patient was not recovered from the event at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus, Rash
Clinical narrative: Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; Shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching.; This is a spontaneous report from a contactable consumer (patient). A 51-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported, patient was 51-year-old and not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 09Apr2021 at 06:15 PM as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history was not reported. The patient previously took humira for colitis ulcerative which can reduce my ability to fight infection. No other vaccine received in four weeks. Other medications received in two weeks. No covid prior vaccination, no covid tested post vaccination. No known allergies reported. On 12Apr2021, the patient experienced shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching. Therapeutic measures were taken as a result of shingles like rash on left side of body in 4 places over 10 days but no pain or blisters, only itching with Steroid ointment and cortisone cream. AE resulted in doctor or other healthcare professional office/clinic visit. The outcomes of events were recovering.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with Herpes Zoster (shingles); This is a spontaneous report from a contactable consumer. This 65-year-old female consumer (patient) reported that: A 65-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 09Feb2021 at 16:30 (at the age of 65-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included High BP, High cholesterol, from an unknown date and unknown if ongoing. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medication(s) included lovastatin (LOVASTATIN); lisinopril (LISINOPRIL) and loratadine (LORATADINE) taken for an unspecified indication, start and stop date were not reported. Patient previously took penicillin and experienced allergies. Patients heroical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL3246), via an unspecified route of administration, administered in Right arm on 19Jan2021 at 16:30 (at the age of 65-year-old) as single dose for covid-19 immunisation. Patient was not received any other vaccine four weeks prior vaccination. The patient experienced diagnosed with herpes zoster on 21Mar2021 at 10:00. Since vaccination patient not tested for covid-19. Event resulted to visit Doctor or other healthcare professional office/clinic. Therapeutic measures were taken as a result of the events with Antiviral. The outcome of the event was reported as recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Menstrual disorder
Clinical narrative: menstrual cycle to start 10 days early; excessive clotting from my period; This is a spontaneous report from a contactable consumer reported for herself. A 24-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8733), dose 2 via an unspecified route of administration, administered in left arm on 22Mar2021 at 10:00 (at the age of 24-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical and concomitant medication history were reported. Historical vaccine included: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8727) (at the age of 24-years-old) as dose 1, single administered in left arm on 22Mar2021 at 18:00 PM for COVID-19 immunization. After first dose it caused menstrual disorder (menstrual cycle to start 4 days early) and dysmenorrhoea (also had cramping the day got the shot). The patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No COVID prior vaccination. Facility type vaccine reported as other. On 16Apr2021, the patient experienced menstrual cycle to start 10 days early and excessive clotting from period. Both times patient had excessive clotting from period which was not something experience with usual cycle. No treatment received for adverse event. No COVD tested post vaccination. The outcome of the events were recovering.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eyelid rash, Fatigue, Headache, Herpes zoster
Clinical narrative: chills; headaches; tiredness; broke our on a rash on left side; rash was on eyelid; more rashes around eyebrows and corner of mouth and underneath lip; shingles; pigmentation; This is a spontaneous report from a contactable (patient) reported that. A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 31Mar2021 (Batch/Lot Number: ER8737) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. Facility type vaccine: Public Health Clinic/Veterans Administration facility. After the 1st shot of vaccine patient reported - regular side effects: sore arm, nausea and feeling off. The patient reported after 24 hrs. of 2nd shot of vaccine experienced chills, headaches, tiredness, no fever within 24 hrs. on 07Apr2021 and week after 2nd shot, broke out on a rash on left side. Started on forehead then by Friday, 09Apr, rash was on eyelid. Went to Eye dry sat and urgent care on Sunday for more rashes around eyebrows and corner of mouth and underneath lip. Went to dermatologist on Tuesday, 13Apr2021 and treated as shingles. The events result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On the mend now but it left some scars and pigmentation issue. The event outcome was recovering.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pigmentation disorder, Rash
Clinical narrative: chills; headaches; tiredness; broke our on a rash on left side; rash was on eyelid; more rashes around eyebrows and corner of mouth and underneath lip; shingles; pigmentation; This is a spontaneous report from a contactable (patient) reported that. A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 31Mar2021 (Batch/Lot Number: ER8737) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. Facility type vaccine: Public Health Clinic/Veterans Administration facility. After the 1st shot of vaccine patient reported - regular side effects: sore arm, nausea and feeling off. The patient reported after 24 hrs. of 2nd shot of vaccine experienced chills, headaches, tiredness, no fever within 24 hrs. on 07Apr2021 and week after 2nd shot, broke out on a rash on left side. Started on forehead then by Friday, 09Apr, rash was on eyelid. Went to Eye dry sat and urgent care on Sunday for more rashes around eyebrows and corner of mouth and underneath lip. Went to dermatologist on Tuesday, 13Apr2021 and treated as shingles. The events result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On the mend now but it left some scars and pigmentation issue. The event outcome was recovering.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Furuncle, Illness, Nausea, Vertigo
Clinical narrative: boil on right side of the labia; ill; nauseous; dizzy; Vertigo; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, NDC: 59267-0100-1, Expiration date: unknown), via an unspecified route of administration in arm right on 01Apr2021 (at the age of 83-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history included allergy to penicillin. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, NDC: 59267-0100-1, Expiration date: unknown), via an unspecified route of administration on an unspecified date as a dose 1, single for COVID-19 immunization. The caller stated that, she was called because she had this number on the phone and had her second Pfizer shot on 01Apr2021 and she became ill, nauseous and dizzy on 05Apr2021. The caller stated that, she was transferred to an emergency room and the only thing they come up was that she had vertigo on 05Apr2021. Stated that, she has never had vertigo in her life, could this be vertigo or could it be a reaction to the vaccine. Treated with something for nausea, no details provided and meclizine for the dizziness, refilled yesterday at the doctor's office plus prednisone, also was taking an antibiotic because she had a boil on right side of the labia on 14Apr2021 and they lanced it. Stated that, the boil was down in the valley, clarified that, on her labia. Stated that, it has improved since taking the antibiotics. Stated that, the doctor gave her some medication, took first round and it has improved, it was still there, has not started to take the second. Stated that, first dose has same NDC number, Lot, Expirations and dosages unknown. Second dose was administered around 11am, right arm. Stated that, she got the vaccine at hospital and they knew about her allergy to penicillin and other allergies. Stated that, the caller did not know the names of the medications. The reporter seriousness for the events was reported as unspecified. The events resulted in emergency room visit. Treatment was received for the event boil on right side of the labia. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Heart rate, Heart rate increased, Heavy menstrual bleeding, Pain
Clinical narrative: Increased resting heart rate (increase of 15bpm); Painful; lots of clotting; heavy period after 1st dose; This is a spontaneous report from a contactable consumer or other non hcp. A 38-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Right Arm on 25Mar2021 14:00 (Age at vaccination 38 years old) (Batch/Lot Number: Er8730) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took neomycin and experienced drug hypersensitivity, bacitracin and experienced drug hypersensitivity, chloraprep and experienced drug hypersensitivity. On an unspecified date the patient experienced Increased resting heart rate (increase of 15bpm) Painful and heavy period after 1st dose with lots of clotting. The patient underwent lab tests and procedures which included heart rate: increase on increase of 15bpm. Outcome of the events was unknown.  No follow-up attempts are required. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Pain in extremity, Vaccination site pain
Clinical narrative: Arm and site pain only.; Arm and site pain only.; My blood pressure is up from pre shot range. 118-128/ 80-86. Now 130-164/ 90-102; This is a spontaneous report from a contactable consumer, the patient. A 62-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208, expiration date not reported), via an unspecified route of administration, administered in left arm on 19Mar2021 (at the age of 62 years) as dose 2, single for covid-19 immunization. Medical history included coronary artery disease, contact dermatitis, both on unknown if ongoing, and ongoing hypertension, all from an unknown date. Patient had known allergies to Penicillin, tylox and lotrel. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6200, expiration date not reported) via unspecified route of administration, administered in left arm on 26Feb2021 (at the age of 62 years) as dose 1, single for covid-19 immunization and experienced arm pain. Patient did not take other vaccine in four weeks. Concomitant medication included amlodipine besilate, benazepril hydrochloride; and rosuvastatin, both taken for an unspecified indication, start and stop date were not reported. On an unknow date, the patient experienced arm and site pain only. Patient blood pressure was up from pre shot range 118-128/ 80-86, now 130-164/ 90-102. Patient did not had covid prior to vaccination and had not been tested for covid since the vaccination. Events resulted in doctor or other healthcare professional office/ clinic visit. Treatment taken for events was unknown. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I had a herpes ( shingles breakout after each vaccine. More severe after second dose.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Left on 18Mar2021 16:30 (at the age of 56 years) (Batch/Lot Number: EP7534) as DOSE NUMBER UNKNOWN, SINGLE via an unspecified route of administration, administered in Arm Left on 26Feb2021 (at the age of 56 years) (Batch/Lot Number: EN6299) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation at Public Health Clinic. The patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. Patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Feb2021 the patient experienced I had a herpes (shingles breakout after each vaccine. More severe after second dose). The treatment received for the event was unknown. The clinical outcome of the event was unknown.  No follow up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chest discomfort, Chills, Fatigue
Clinical narrative: sore arm; feeling pressure in my chest; chills; fatigued; chest was pounding; BP was 155/102. Mine is normally 120/78 so very high for me; This is a spontaneous report from a contactable consumer. A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER6955, Expiration date was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 16Apr2021 14:45 (age at vaccination 44 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no allergies. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP6955, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 19Mar2021 14:45 as dose 1, single for covid-19 immunisation and suffered from sore pain. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 19:00 the patient experienced sore arm, feeling pressure in my chest, chills, fatigued, fell asleep at 9:00 pm, woke up at 10:30 pm chest was pounding, bp was 155/102. mine is normally 120/78 so very high for me. The patient underwent lab tests and procedures which included blood pressure measurement was 120/78 (Mine is normally 120/78), blood pressure measurement was 155/102 on 17Apr2021 BP was (155/102). Patient did not receive any treatment for occurred events. The outcome of event was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations
Clinical narrative: sore arm; feeling pressure in my chest; chills; fatigued; chest was pounding; BP was 155/102. Mine is normally 120/78 so very high for me; This is a spontaneous report from a contactable consumer. A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER6955, Expiration date was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 16Apr2021 14:45 (age at vaccination 44 years) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no allergies. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EP6955, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 19Mar2021 14:45 as dose 1, single for covid-19 immunisation and suffered from sore pain. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 19:00 the patient experienced sore arm, feeling pressure in my chest, chills, fatigued, fell asleep at 9:00 pm, woke up at 10:30 pm chest was pounding, bp was 155/102. mine is normally 120/78 so very high for me. The patient underwent lab tests and procedures which included blood pressure measurement was 120/78 (Mine is normally 120/78), blood pressure measurement was 155/102 on 17Apr2021 BP was (155/102). Patient did not receive any treatment for occurred events. The outcome of event was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Folliculitis, Headache, Lethargy, Lymph node pain
Clinical narrative: SEVERE headache that will not go away.; Chills; Fever; Body aches; Lethargy; Lymph node swelling and pain; Lymph node swelling and pain; Rash on face; painful sores on scalp; painful sores on scalp; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 42-year-old female patient received BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- UNKNOWN) via an unspecified route of administration in right arm on 19Apr2021 as dose 2, single (at the age of 42-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history was reported as none. Patient had no known allergies. The concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 28Mar2021 15:00 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks. The patient experienced severe headache that will not go away, chills, fever, body aches, lethargy, lymph node swelling and pain, rash on face, painful sores on scalp, on 20Apr2021. The patient did not receive any treatment for the events. Facility type vaccine was Pharmacy or drug store. The outcome of the events was resolved with sequelae on an unspecified date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pain of skin, Pyrexia, Rash
Clinical narrative: SEVERE headache that will not go away.; Chills; Fever; Body aches; Lethargy; Lymph node swelling and pain; Lymph node swelling and pain; Rash on face; painful sores on scalp; painful sores on scalp; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 42-year-old female patient received BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- UNKNOWN) via an unspecified route of administration in right arm on 19Apr2021 as dose 2, single (at the age of 42-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history was reported as none. Patient had no known allergies. The concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: UNKNOWN) via an unspecified route of administration in left arm on 28Mar2021 15:00 as dose 1, single for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks. The patient experienced severe headache that will not go away, chills, fever, body aches, lethargy, lymph node swelling and pain, rash on face, painful sores on scalp, on 20Apr2021. The patient did not receive any treatment for the events. Facility type vaccine was Pharmacy or drug store. The outcome of the events was resolved with sequelae on an unspecified date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Migraine, Pain, Pruritus, SARS-CoV-2 antibody test
Clinical narrative: I developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. I even went to my neurologists office for an IV treatment. After 8-9 days of he; developed shingles rash on my right thigh and next to my right knee; extremely painful and itchy; extremely painful and itchy; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.   A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL6202 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 27Feb2021 10:30 as DOSE 1, SINGLE for covid-19 immunization. Medical history included migraine from an unknown date and unknown if ongoing Relevant medical history: Migraine , bronchiectasis from an unknown date and unknown if ongoing Relevant medical history: bronchiectasis , pain from an unknown date and unknown if ongoing Relevant medical history: chronic pain , depression from an unknown date and unknown if ongoing Relevant medical history: depression. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination. The patient was not diagnosed with Covid 19 and has been tested for Covid-19 Since the vaccination. The patient previously took codeine and experienced drug hypersensitivity, sumatriptan and experienced drug hypersensitivity, levaquin and experienced drug hypersensitivity, bactrim and experienced drug hypersensitivity. On 23Mar2021 15:00 the patient experienced i developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. i even went to my neurologists office for an iv treatment. after 8-9 days of he, developed shingles rash on my right thigh and next to my right knee, extremely painful and itchy. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 06Apr2021 .Therapeutic measures were taken as a result of i developed a migraine within a few days of my 2nd vaccine that would not respond to any of my prescription rescue meds. i even went to my neurologists office for an iv treatment. after 8-9 days of he, developed shingles rash on my right thigh and next to my right knee, extremely painful and itchy, extremely painful and itchy , treatment included for Migraine, Antiviral meds for rash. The outcome of event was  recovering.  No Follow-up attempts are needed. No further Information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Hyperaesthesia, Rash
Clinical narrative: rash developed 23Apr; Diagnosed with Shingles on 4-23-21; skin sensitivity on thigh on 18Apr; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0151, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 08Apr2021 14:30 at the age of 56-year-old as dose 1, single for COVID-19 immunization, at pharmacy. The patient medical history included DVT (deep vein thrombosis) and PE (pulmonary embolism) in 2014. The patient had known allergies to sulfa drugs and latex. The concomitant medications included Multivitamins. The patient was not pregnant at the time of vaccination. The patient received no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. It was reported that, the first symptoms appeared skin sensitivity on thigh on 18Apr2021 at 20:00. The patient was diagnosed with shingles on 4-23-21 and rash developed on 23Apr2021 at 20:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient received antivirals as treatment for the events. The outcome of the events was reported as resolving.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Herpes zoster (shingles); This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: ER8733) via an unspecified route of administration (age at vaccination 52-year) in left arm on 29Mar2021 at 10:45 AM as dose 1, single for COVID-19 immunization. Medical history included gitelman's syndrome, COVID-19 (Prior vaccination), both from an unknown date and unknown if ongoing If. Concomitant medications included metoprolol; topiramate; erenumab aooe (AIMOVIG); acetaminophen (Excedrin TH); gliclazide, metformin hydrochloride (WALFORMIN); all medications taken in twoweeks of vaccination, for an unspecified indication, start and stop date were not reported. Patient received no other vaccine in fourweeks. The patient not tested COVID post vaccination. No known allergies were reported. On 11Apr2021 at 09:30 PM the patient experienced herpes zoster (shingles) of trigeminal nerve with ocular involvement. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of herpes zoster, the patient was treated with antiviral medication (valacyclovir). The clinical outcome of the event was resolving.  No follow-up attempts are required. No further information is expected.